Transactions
Deal Showcase
$125 Million
Joint Bookrunner
Follow-On
February 2023
More Transactions
$119 Million
Joint Bookrunner
Follow-On
October 2021
$150 Million
Joint Bookrunner
Follow-On
December 2023
$35 Million
Exclusive Financial Advisor
Series C Financing Led by MultiPlan Corporation
June 2022
Featured Insights
Podcasts
November 2026
How Are JCA and the EU Pharma Package Changing the Economics of Drug Development? A Perspective from Graham Cookson
Featured Research
October 2026
ESMO 2026: Key Non-LBA Abstracts in Our Targeted Oncology Universe
Articles
October 2026
The Opportunity for Innovation in the Primary Prevention of Cardiovascular Disease
